alanine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jambrosic, JC; Navratilova, E; Roeske, WR; Stropova, D; Varga, EV; Yamamura, HI | 1 |
1 other study(ies) available for alanine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Article | Year |
---|---|
Mutation S363A in the human delta-opioid receptor selectively reduces down-regulation by a peptide agonist.
Topics: Alanine; Amino Acid Substitution; Benzamides; Down-Regulation; Enkephalin, D-Penicillamine (2,5)-; Humans; Mutation; Piperazines; Receptors, Opioid, delta; Serine | 2004 |